Sårbehandling

Study showing that Mepitel Film prevents radiotherapy skin reactions becomes news

Av: Mölnlycke Health Care, mai 21 2014Postet i: Sårbehandling

Radiation-induced skin reactions occur in 80-90% of breast cancer patients1 and can range from mild redness to ulceration, with symptoms of pain, burning and itchiness.  This can have a very negative impact on day to day life for patients, who already have to cope with being diagnosed with and treated for cancer.  

However, a study2 conducted in New Zealand has shown that the use of Mepitel Film, a thin, transparent dressing using Mölnlycke Health Care’s Safetac® technology, before, during and after radiation therapy, prevents the development of moist desquamation and reduces the severity of other skin reactions.

78 patients undergoing radiation therapy for breast cancer took part in the trial.  Each patient’s irradiated skin area was divided into two halves, with Mepitel Film used on one side and aqueous cream on the other.  The study found that there were no cases of ulceration or severe skin reactions on the skin under Mepitel Film, whilst cream-treated skin developed these wounds in 26% of patients.  In addition, the skin reactions that did develop under Mepitel Film were 92% less severe than in the cream-treated control group.

These conclusive findings were picked up by TVNZ ONE News and broadcast as a feature news item in their nightly news bulletin. The story mainly focused on the study’s core fundamental: that when Mepitel Film is used from the very first day of treatment, skin reactions severity is reduced by 92%. The full news item can be seen here.

References:

  1. Wells M (2003) Radiation skin reactions. Faithfull S (Ed) Supportive care in radiotherapy. London: Churchill Livingstone 135-159.
  2. Herst PM et al. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol (2014)
Del dette

Mer fra den samme kategori

Spør ekspertene om bandasjens rolle...

Some of the world’s leading experts will take part in an outstanding symposium...

Mepilex Border Heel

  // The well established and highly successful product range of Mepilex® Border continues to...

EWMA trykksår symposiumrapport

The EWMA delegates who attended the Mölnlycke Health Care seminar on...

Mepilex Transfer Ag

  // The efficacy of wound contact layer dressings with antimicrobial properties in clinical...

Mepilex Border Post-Op

  // The need for a reliable, surgically safe post-operative wound dressing for both clinical...

Bandasjens Konstruksjon: Bruk av flerlags...

During this year’s World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - et viktig element i sårbehandling:...

A recently published French study has confirmed the effectiveness of...

EWMA symposiumrapport om hvordan smerte...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

Kliniske tester viser at bandasjer er...

Hospital acquired pressure ulcers are a major challenge for medical practitioners....

Produktnyhet: Mepilex XT

Hittil har ikke skumbandasjer klart å håndtere tyktflytende sårvæske effektivt. Dette gjorde at...

Gode resultater med Mepilex XT

Ved Södersjukhuset i Sverige har de evaluert skumbandasjen Mepilex XT. ...

Exufiber ga Toivo tilbake hans normale...

Sår som heler langsomt krever ofte masse tid av helsepersonell, stort engasjement...